Table 2.
Age-band (years) | IFR (%) without seroreversion (95% PI) | IFR (%) with seroreversion (95% PI) |
---|---|---|
0–4 | 0 (0, 0.04) | 0 (0, 0.04) |
5–9 | 0.01 (0, 0.07) | 0.01 (0, 0.07) |
10–14 | 0.01 (0, 0.12) | 0.01 (0, 0.11) |
15–19 | 0.02 (0, 0.2) | 0.02 (0, 0.19) |
20–24 | 0.03 (0, 0.32) | 0.03 (0, 0.31) |
25–29 | 0.04 (0, 0.5) | 0.04 (0, 0.48) |
30–34 | 0.07 (0.01, 0.75) | 0.06 (0.01, 0.72) |
35–39 | 0.1 (0.01, 1.09) | 0.1 (0.01, 1.05) |
40–44 | 0.16 (0.02, 1.54) | 0.16 (0.02, 1.47) |
45–49 | 0.25 (0.03, 2.11) | 0.24 (0.03, 2.02) |
50–54 | 0.4 (0.06, 2.84) | 0.38 (0.05, 2.7) |
55–59 | 0.62 (0.1, 3.75) | 0.59 (0.1, 3.56) |
60–64 | 0.96 (0.19, 4.9) | 0.92 (0.18, 4.64) |
65–69 | 1.5 (0.35, 6.38) | 1.43 (0.34, 6.03) |
70–74 | 2.34 (0.66, 8.31) | 2.23 (0.63, 7.85) |
75–79 | 3.66 (1.23, 10.9) | 3.47 (1.18, 10.27) |
80–84 | 5.71 (2.26, 14.44) | 5.41 (2.16, 13.59) |
85–89 | 8.9 (4.09, 19.37) | 8.43 (3.91, 18.21) |
90+ | 17.36 (9.73, 30.97) | 16.4 (9.25, 29.08) |
Overall (LIC) | 0.24 (0.15, 0.43) | 0.23 (0.14, 0.41) |
Overall (LMIC) | 0.4 (0.27, 0.68) | 0.39 (0.25, 0.65) |
Overall (UMIC) | 0.62 (0.41, 1.01) | 0.59 (0.39, 0.97) |
Overall (HIC) | 1.16 (0.79, 1.82) | 1.1 (0.75, 1.72) |
Bold and Italic values represent the overall numbers at the end.
IFR estimates were calculated by combining study- and age-specific IFR estimates in a log-linear model. The median predicted estimate and corresponding 95% prediction intervals (PIs) are shown above. Predictive intervals were used to express the plausible range of IFRs that can be expected in a new study population, rather than showing our degree of certainty of our estimates with confidence intervals. For the 90+ age group, we assumed a maximum age of 100 years. The overall IFR estimates were standardised by the population structure in a representative low-income country (LIC), low-middle income country (LMIC), upper-middle income country (UMIC), and high-income country (HIC), assuming equal attack rates across age groups.